» Articles » PMID: 36678843

Magnetic Platelets As a Platform for Drug Delivery and Cell Trapping

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2023 Jan 21
PMID 36678843
Authors
Affiliations
Soon will be listed here.
Abstract

The possibility of using magnetically labeled blood cells as carriers is a novel approach in targeted drug-delivery systems, potentially allowing for improved bloodstream delivery strategies. Blood cells already meet the requirements of biocompatibility, safety from clotting and blockage of small vessels. It would solve the important problem of the patient's immune response to embedded foreign carriers. The high efficiency of platelet loading makes them promising research objects for the development of personalized drug-delivery systems. We are developing a new approach to use platelets decorated with magnetic nanoparticles as a targeted drug-delivery system, with a focus on bloodstream delivery. Platelets are non-nuclear blood cells and are of great importance in the pathogenesis of blood-clotting disorders. In addition, platelets are able to attach to circulating tumor cells. In this article, we studied the effect of platelets labeled with BSA-modified magnetic nanoparticles on healthy and cancer cells. This opens up broad prospects for future research based on the delivery of specific active substances by this method.

Citing Articles

Multi-omics approaches for understanding gene-environment interactions in noncommunicable diseases: techniques, translation, and equity issues.

Alemu R, Sharew N, Arsano Y, Ahmed M, Tekola-Ayele F, Mersha T Hum Genomics. 2025; 19(1):8.

PMID: 39891174 PMC: 11786457. DOI: 10.1186/s40246-025-00718-9.


A Platelet-Powered Drug Delivery System for Enhancing Chemotherapy Efficacy for Liver Cancer Using the Trojan Horse Strategy.

Huang H, Wang X, Gao Z, Bao H, Yuan X, Chen C Pharmaceutics. 2024; 16(7).

PMID: 39065602 PMC: 11279470. DOI: 10.3390/pharmaceutics16070905.

References
1.
Ye H, Tong J, Wu J, Xu X, Wu S, Tan B . Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma. Int J Nanomedicine. 2014; 9:4533-50. PMC: 4184408. DOI: 10.2147/IJN.S67228. View

2.
Sindeeva O, Verkhovskii R, Abdurashitov A, Voronin D, Gusliakova O, Kozlova A . Effect of Systemic Polyelectrolyte Microcapsule Administration on the Blood Flow Dynamics of Vital Organs. ACS Biomater Sci Eng. 2021; 6(1):389-397. DOI: 10.1021/acsbiomaterials.9b01669. View

3.
Li N . Platelets in cancer metastasis: To help the "villain" to do evil. Int J Cancer. 2015; 138(9):2078-87. DOI: 10.1002/ijc.29847. View

4.
Su Y, Xie Z, Kim G, Dong C, Yang J . Design strategies and applications of circulating cell-mediated drug delivery systems. ACS Biomater Sci Eng. 2015; 1(4):201-217. PMC: 4428174. DOI: 10.1021/ab500179h. View

5.
Nosrati H, Sefidi N, Sharafi A, Danafar H, Manjili H . Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug. Bioorg Chem. 2018; 76:501-509. DOI: 10.1016/j.bioorg.2017.12.033. View